Align Technology (NASDAQ:ALGN) Releases Earnings Results, Beats Estimates By $0.03 EPS

Align Technology (NASDAQ:ALGN) released its quarterly earnings results on Wednesday. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.77 by $0.03, FiscalAI reports. Align Technology had a return on equity of 16.11% and a net margin of 11.83%. The business had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $1 billion. During the same quarter last year, the business posted $2.61 EPS. The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year.

Here are the key takeaways from Align Technology’s conference call:

• Q3 revenue reached $1.015 billion, up 1.9% year over year, while clear aligner shipments rose 6.6% to a record 691,000 and doctor submitters reached a record 91,000. Utilization improved 3.4%, with broad international growth and strong DSO performance.
• Profitability improved despite a challenging demand environment: non-GAAP operating margin increased to 24.4%, and non-GAAP EPS rose 7.3% to $2.80. Align also plans to repurchase approximately $500 million of stock in 2026.
• Management lowered its near-term outlook, citing continued consumer softness and weaker capital-equipment demand. Q4 revenue is expected at $1.00 billion-$1.02 billion, with low-single-digit clear aligner volume growth and systems-and-services revenue of $170 million-$180 million; full-year revenue is now projected at $4.11 billion-$4.13 billion.
• Align expects continued clear aligner volume growth and at least 100 basis points of non-GAAP operating-margin expansion in 2027 without assuming a consumer recovery. Scanner unit placements are growing, but revenue is being pressured by lower-priced configurations, leasing, rentals, and other flexible acquisition models.
• CEO Joe Hogan will step down at year-end, with Jennifer Davis, a former Procter & Gamble healthcare executive, becoming CEO and president on December 31. Align also plans to pilot a premium, 3D-printed sports mouth guard through Invisalign providers, expanding the potential use of its printing technology beyond orthodontic appliances.

Align Technology Stock Up 0.1%

Shares of NASDAQ:ALGN opened at $153.71 on Friday. The stock has a market cap of $11.01 billion, a P/E ratio of 16.47, a PEG ratio of 1.65 and a beta of 1.67. The business has a fifty day moving average of $150.64 and a two-hundred day moving average of $168.87. Align Technology has a 52-week low of $130.23 and a 52-week high of $200.43.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ALGN. Evercore cut shares of Align Technology from an “outperform” rating to an “in-line” rating and set a $155.00 price objective on the stock. in a research report on Monday, October 5th. Needham & Company LLC restated a “hold” rating on shares of Align Technology in a report on Thursday. Mizuho lowered their target price on shares of Align Technology from $220.00 to $200.00 and set an “outperform” rating for the company in a research note on Thursday, October 22nd. Wall Street Zen lowered shares of Align Technology from a “buy” rating to a “hold” rating in a research report on Saturday, October 24th. Finally, Raymond James Financial reiterated a “buy” rating on shares of Align Technology in a research note on Monday, October 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $190.00.

More Align Technology News

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q3 results topped expectations: Align reported adjusted EPS of $2.80 versus the $2.77 consensus and revenue of approximately $1.015 billion versus estimates near $1.0 billion. Clear-aligner shipments increased 6.6% year over year to 690,635, while clear-aligner revenue rose 4.2% to $839.3 million. Align Technology Announces Third Quarter 2026 Financial Results
• Positive Sentiment: Profitability and capital returns provided support: GAAP net income rose to $135.0 million from $56.8 million a year earlier, and Align repurchased roughly 627,300 shares during the quarter. The company expects to repurchase up to $300 million of stock in the fourth quarter. Align Technology Q3 Revenue Reaches $1.015 Billion as Net Income Rises
• Neutral Sentiment: Near-term guidance was mixed: Align forecast fourth-quarter revenue of $1.00 billion to $1.02 billion. That outlook is broadly consistent with current quarterly revenue, but investors are weighing it against a reduced 2026 sales outlook. Align Technology Provides Earnings Guidance
• Negative Sentiment: Lowered 2026 sales expectations outweighed the earnings beat: The revised outlook signals that growth may remain constrained, contributing to the stock’s decline as investors prioritize future revenue over the strong quarterly headline numbers. ALGN Q3 Earnings and Revenues Beat, 2026 Sales View Down
• Negative Sentiment: Analysts reduced price targets: Jefferies cut its target to $170 from $185, while Morgan Stanley lowered its target to $175 from $188. These revisions reinforce concerns about Align’s growth trajectory and valuation. Jefferies Adjusts Price Target
• Negative Sentiment: CEO succession and management changes add uncertainty: Align announced a CEO succession plan along with board and management changes. Even without details on the long-term impact, leadership transition risk is another factor weighing on investor sentiment. Align Technology Announces CEO Succession Plan

About Align Technology

Align Technology, Inc is a global medical device company focused on digital orthodontics and restorative dentistry. Founded in 1997, the company is best known for the Invisalign system, a series of clear, removable aligners designed to gradually move teeth and treat a range of orthodontic conditions.

Align’s products and services also include digital scanning and dental practice solutions. Its iTero intraoral scanners create digital impressions for orthodontic and restorative procedures, while its exocad business develops computer-aided design and computer-aided manufacturing software used by dental laboratories, clinicians and other dental professionals.

The company serves orthodontists, dentists, dental laboratories and patients in numerous markets worldwide.